VSEE HEALTH, INC. (VSEE): Nasdaq/NYSE listing notice — Digital Health Acquisition Corp. receives Nasdaq delisting notice for MVPHS deficiency

VSEE HEALTH, INC.

Nasdaq notifies that MVPHS stayed below $15M for 30 consecutive business days through May 23, 2023.
Company has 180 days, until November 20, 2023, to regain compliance with the MVPHS requirement.
Options to cure include raising MVPHS above $15M for 10 consecutive days or transferring to Nasdaq Capital Market.
No immediate effect on listing or trading; company will monitor and evaluate available options.
No assurance that compliance will be regained or continued listing maintained.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

VSEE HEALTH, INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C), 5810(c)(3)(D)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(3)(C), 5810(c)(3)(D)

Exact text from the filing

May 23, 2023, Digital Health Acquisition Corp., a Delaware corporation (the “Company”), received a letter (the “Letter”) from the Listing Qualifications Staff (“Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”). The Letter notifies the Company that for the 30 consecutive business days prior to the date of the Letter, the Company’s market value of publicly held shares (“MVPHS”) was below the $15 million required for continued listing on the Nasdaq Global Market (the “Nasdaq Global”) and therefore, the Company no longer meets Nasdaq Listing Rule 5450(b)(3)(C) (the “MVPHS Requirement”). The Lette

View on SEC.gov

Browse all listing & compliance notices →

VSEE HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-065553

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.